Yunseon Chong

Yunseon Chong has had extensive experience in the pharmaceutical and biotechnology industry. From 2018 to the present, Chong has been working as the Director of Business Development at Bridge Biotherapeutics, Inc. Prior to this, Chong worked as a Clinical Operations Consultant at ImmunoMet Therapeutics from 2016 to 2018. From 2014 to 2015, Chong served as an Associate Director at PAREXEL. In 2013, Chong held the position of Director of Strategic Planning at Korea Drug Development Fund. Chong's longest tenure was at Pfizer, where they held multiple roles including Head of Clinical Operations from 2010 to 2012, Clinical Research Manager from 2006 to 2010, Clinical Research Associate from 2002 to 2006, and Discovery Research Informatics Intern/Research Assistant from 2001 to 2002.

Yunseon Chong holds a Bachelor of Science (BS) degree in Food Science & Microbial Technology from Seoul Women's University, which was obtained from 1993 to 1998. Following that, Chong pursued a Master of Science (MS) degree in Toxicology at the University of Michigan between 1999 and 2001. Lastly, Chong attended Northwestern University from 2010 to 2011, where they earned a Master of Science in Law (MSL) degree, specializing in Executive LLM.